Effect of synergism of small molecules against fibrillation process of human serum albumin
There are different ways by which small molecules interact with protein and its aggregates. One of it is synergistic interaction of drugs or small molecules against protein aggregates.
Protein aggregation is a common cause of neurodegeneration. Most of the proteins which are commonly involved in degeneration are α-synuclein, Aβ-peptide, tau, prion protein etc.
Intermolecular interaction, increase in hydrophobicity of human serum albumin (HSA) at high temperature is the mechanism of aggregation which is similar to α-synuclein aggregation mechanism.
The observation of this study has revealed that benserazide hydrochloride (BH), levodopa (LD) when added simultaneously together to human serum albumin (HSA) sample and incubated under thermal condition showed maximum inhibition of amyloid fibrils as compared to the individual drugs (Fig. 1).
The reason for enhanced activity of the two drugs together was confirmed by the analysis of the combination index (CI) of those drugs and it was found to be 0.39 (CI<1 for synergism). This established the synergism between BH and LD.
Further, this hypothesis was analyzed on SH SY5Y cell lines. The outcome showed the corresponding result. The effect of BH+LD on the viability of SH SY5Y cells was more constructive as compared to BH and LD individually (Fig. 2).
Thus, synergism is a modern mechanism of inhibition of amyloid fibrils that was found to be more promising as compared to the traditional one.
Tajalli Ilm Chandel, Rizwan Hasan Khan
Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, U.P. India
A multiparametric analysis of the synergistic impact of anti-Parkinson’s drugs on the fibrillation of human serum albumin
Tajalli Ilm Chandel, Nida Zaidi, Masihuz Zaman, Ishrat Jahan, Aiman Masroor, Ibrar Ahmad Siddique, Shahid M Nayeem, Maroof Ali, Vladimir N Uversky, Rizwan Hasan Khan
Biochim Biophys Acta Proteins Proteom. 2019 Mar